Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13101763
Abstract: This real-world cohort analysis assessed the efficacy of alpelisib and endocrine treatment (ET) combinations in a post-everolimus setting. Thirteen women who started alpelisib and ET at standard doses between 2018 and 2022 for advanced breast… read more here.
Keywords: post everolimus; advanced breast; everolimus treatment; breast cancer ... See more keywords